Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib (Q36006408)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib |
scientific article |
Statements
1 reference
Chronic phase chronic myeloid leukemia patients with low OCT-1 activity randomized to high-dose imatinib achieve better responses and have lower failure rates than those randomized to standard-dose imatinib (English)
1 reference
Giovanni Martinelli
1 reference
Fabrizio Pane
1 reference
Daniela Cilloni
1 reference
Richard Woodman
1 reference
Jerald Radich
1 reference
Verity A Saunders
1 reference
Amity K Frede
1 reference
Phuong Dang
1 reference
Peter Lin
1 reference
Lidia Mongay
1 reference
Paul Manley
1 reference
Cassandra Slader
1 reference
Dong Wook Kim
1 reference
Timothy P Hughes
1 reference
29 December 2011
1 reference
1 reference
907-914
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference